The effects of Levocarnitine combined with Sacubitril valsartan on incidence of infectious diseases, renal and cardiac function, and blood indicators in elderly patients with chronic renal failure complicated with heart failure

Key Points

• This research aims to evaluate the effects of levocarnitine combined with sacubitril valsartan on various health outcomes in elderly patients suffering from chronic renal failure and heart failure.
• Randomized trial involving elderly patients with chronic renal failure and heart failure.
• Participants received levocarnitine in combination with sacubitril valsartan.
• Outcomes measured include incidence of infections, renal and cardiac function, and blood indicators.
• Significant reduction in the incidence of infectious diseases compared to control group (exact rates not provided).
• Improvement in renal function metrics observed, with relevant percentages or metrics forthcoming.
• Enhanced cardiac function markers noted, indicating better overall heart health.